-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Liw89tQ9Ksk9cExBWpclTXq1hgKjmlFKZghQKgH+ERy8Dc6EZ4UFGW6tTpRgJHKX Ozlx2E//6aRW9Pfd3dOSWw== 0001179110-06-016718.txt : 20060815 0001179110-06-016718.hdr.sgml : 20060815 20060815135309 ACCESSION NUMBER: 0001179110-06-016718 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060814 FILED AS OF DATE: 20060815 DATE AS OF CHANGE: 20060815 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: WATSON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884629 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 953872914 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 311 BONNIE CIRCLE CITY: CORONA STATE: CA ZIP: 92880 BUSINESS PHONE: 9092701400 MAIL ADDRESS: STREET 1: 311 BONNIE CIRCLE CITY: CORONA STATE: CA ZIP: 92880 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HSIA DAVID C CENTRAL INDEX KEY: 0001258176 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13305 FILM NUMBER: 061034390 MAIL ADDRESS: STREET 1: C/O WATSON PHARMACEUTICALS, INC. STREET 2: 311 BONNIE CIRCLE CITY: CORONA STATE: CA ZIP: 92880 4 1 edgar.xml FORM 4 - X0202 4 2006-08-14 0 0000884629 WATSON PHARMACEUTICALS INC WPI 0001258176 HSIA DAVID C C/O WATSON PHARMACEUTICALS, INC. 311 BONNIE CIRCLE CORONA CA 92880 0 1 0 0 Sr. VP, Scientific Affairs Common Stock, par value $0.0033 2006-08-14 4 M 0 15000 13.75 A 76333 D Common Stock, par value $0.0033 732085 I by Family Trust Common Stock, par value $0.0033 1004218 I by Partnership Common Stock, par value $0.0033 40000 I by Trust Non-Qualified Options to Purchase Common Stock 13.75 2006-08-14 4 M 0 15000 0 D 2001-08-19 2006-08-19 Common Stock, par value $0.0033 15000 0 D This includes 1,333 shares of restricted stock issued pursuant to the Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc. By Family Trust refers to the Hsia Family Trust, of which Dr. Hsia is a beneficial owner. By Partnership refers to the Hsia Interests, Ltd., of which Dr. Hsia is a general partner. /s/DAVID C. HSIA 2006-08-15 -----END PRIVACY-ENHANCED MESSAGE-----